Liu T - Search Results

1

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.

Gong J, Liu T, Fan Q, Bai L, Bi F, Qin S, Wang J, Xu N, Cheng Y, Bai Y, Liu W, Wang L, Shen L. Gong J, et al. Among authors: liu w, liu t. BMC Cancer. 2016 Feb 8;16:68. doi: 10.1186/s12885-016-2092-9. BMC Cancer. 2016. PMID: 26857702 Free PMC article. Clinical Trial.

2

Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.

Cui Y, Li Q, Yu Y, Chen Y, Feng Y, Wang Y, Liu T. Cui Y, et al. Among authors: liu t. Cancer Chemother Pharmacol. 2013 Jan;71(1):145-52. doi: 10.1007/s00280-012-1991-y. Epub 2012 Oct 12. Cancer Chemother Pharmacol. 2013. PMID: 23064955 Clinical Trial.

3

Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai.

Cai X, Cao W, Ding H, Liu T, Zhou X, Wang M, Zhong M, Zhao Z, Xu Q, Wang L. Cai X, et al. Among authors: liu t. J Cancer Res Clin Oncol. 2013 Sep;139(9):1579-89. doi: 10.1007/s00432-013-1480-7. Epub 2013 Jul 28. J Cancer Res Clin Oncol. 2013. PMID: 23892411 Free PMC article.

4

Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients.

Li W, Xu J, Shen L, Liu T, Guo W, Zhang W, Chen Z, Zhu X, Li J. Li W, et al. Among authors: liu t. BMC Cancer. 2014 Dec 19;14:986. doi: 10.1186/1471-2407-14-986. BMC Cancer. 2014. PMID: 25527007 Free PMC article. Clinical Trial.

5

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.

Wang J, Xu R, Li J, Bai Y, Liu T, Jiao S, Dai G, Xu J, Liu Y, Fan N, Shu Y, Ba Y, Ma D, Qin S, Zheng L, Chen W, Shen L. Wang J, et al. Among authors: liu y, liu t. Gastric Cancer. 2016 Jan;19(1):234-44. doi: 10.1007/s10120-015-0457-4. Epub 2015 Jan 21. Gastric Cancer. 2016. PMID: 25604851 Free PMC article. Clinical Trial.

6

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial.

Li J, Qin S, Xu R, Yau TC, Ma B, Pan H, Xu J, Bai Y, Chi Y, Wang L, Yeh KH, Bi F, Cheng Y, Le AT, Lin JK, Liu T, Ma D, Kappeler C, Kalmus J, Kim TW; CONCUR Investigators. Li J, et al. Among authors: liu t. Lancet Oncol. 2015 Jun;16(6):619-29. doi: 10.1016/S1470-2045(15)70156-7. Epub 2015 May 13. Lancet Oncol. 2015. PMID: 25981818 Clinical Trial.

7

Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma.

Guo M, Yu Y, Wang Y, Cui Y, Li Q, Feng Y, Li W, Zhuang R, Liu T. Guo M, et al. Among authors: liu t. Med Oncol. 2015 Sep;32(9):230. doi: 10.1007/s12032-015-0675-y. Epub 2015 Aug 13. Med Oncol. 2015. PMID: 26268397 Clinical Trial.

8

Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study.

Li Q, Jiang H, Li H, Xu R, Shen L, Yu Y, Wang Y, Cui Y, Li W, Yu S, Liu T. Li Q, et al. Among authors: liu t. Oncotarget. 2016 Aug 2;7(31):50656-50665. doi: 10.18632/oncotarget.10456. Oncotarget. 2016. PMID: 27409420 Free PMC article.

9

Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.

Wang Z, Liang L, Yu Y, Wang Y, Zhuang R, Chen Y, Cui Y, Zhou Y, Liu T. Wang Z, et al. Among authors: liu t. Cell Physiol Biochem. 2016;39(3):1239-46. doi: 10.1159/000447829. Epub 2016 Sep 5. Cell Physiol Biochem. 2016. PMID: 27595400 Free article.

10

Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study.

Xu RH, Li J, Bai Y, Xu J, Liu T, Shen L, Wang L, Pan H, Cao J, Zhang D, Fan S, Hua Y, Su W. Xu RH, et al. Among authors: liu t. J Hematol Oncol. 2017 Jan 19;10(1):22. doi: 10.1186/s13045-016-0384-9. J Hematol Oncol. 2017. PMID: 28103904 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,073 results

Search Page

Filters